Sex and Gender Identification and Implications for Disability Evaluation (2024)

Chapter: Appendix A: Public Meeting Agendas

Previous Chapter: 14 Overall Conclusions
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.

Appendix A

Public Meeting Agendas

COMMITTEE ON SEX AND GENDER IDENTIFICATION AND IMPLICATIONS FOR DISABILITY EVALUATION

MEETING 1

MAY 30, 2023
VIRTUAL

3:30 p.m. Welcome and Introductions
Hortensia Amaro (she/her), Committee Chair
Steve Rollins, Acting Associate Commissioner, U.S. Social Security Administration (SSA)
3:40 p.m. Social Security Administration Overview
Vincent Nibali, Technical Expert, Office of Medical Policy, Office of Disability Policy, SSA
  • Sponsor perspective/motivations for the study
  • Overview of SSA disability determination process
4:05 p.m. Questions and Discussion
Committee Members and SSA Staff
4:35 p.m. Adjourn Public Session
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.

MEETING 2

JULY 19, 2023
NATIONAL ACADEMY OF SCIENCES BOARD ROOM

The National Academy of Sciences
2101 Constitution Ave NW
Washington, DC 20418

1:30 p.m. Welcome
Hortensia Amaro (she/her), Committee Chair
1:35 p.m. Presentation and Discussion: Chronic Kidney Disease: Sex Differences, Impact of Gender-Affirming Care, and Appropriate Evaluation Criteria

Sofia Ahmed, M.D., MMSc, FRCPC (she/her), Professor, Cumming School of Medicine, University of Calgary; Nephrologist, Alberta Health Services—Calgary Zone

David Collister, M.D., Ph.D., FRCPC (he/him), Assistant Professor, Faculty of Medicine & Dentistry—Medicine Dept, University of Alberta

2:25 p.m. Presentation and Discussion: Breaking the Gender–Cancer Association: Lessons from Quality Measurement for Preventive Screenings

Rachel Harrington, Ph.D. (she/her), Senior Research Scientist, Health Equity, National Committee for Quality Assurance

3:15 p.m. Statement of Task Q&A
3:20 p.m. Closing Remarks
Hortensia Amaro (she/her), Committee Chair
3:20 p.m. Adjourn Public Session
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.

MEETING 3

SEPTEMBER 14, 2023
KECK 209

The Keck Center,
500 Fifth Street, NW
Washington, DC 20001

1:30 p.m. Welcome and Opening Remarks
Hortensia Amaro (she/her), Committee Chair
1:35 p.m. Presentation and Discussion: Gender Identity Data Collection and Care Decision Making within the Veterans Health Administration

Lexi Matza, Ph.D. (they/them/theirs), Associate Director for Data & Analytics, LGBTQ+ Health Program, Patient Care Services, Veterans Health Administration

2:35 p.m. Presentation and Discussion: Selecting Appropriate Pulmonary Function Test Reference Sex for Transgender and Gender Diverse Patients

Ethan Fechter-Leggett, D.V.M., M.P.V.M. (he/him), Research Epidemiologist, Field Studies Branch, Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention

Dinah Foer, M.D. (she/her), Assistant Professor, Harvard Medical School, Associate Physician, Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital

3:30 p.m. Presentation and Discussion: Sexual Orientation and Gender Identity Data Collection in Electronic Medical Records

Carl Streed Jr., M.D., M.P.H., FACP (he/him/his), Assistant Professor of Medicine, Section of General Internal Medicine, Boston University Aram V. Chobanian & Edward Avedisian School of Medicine; Research Lead, GenderCare Center, Boston Medical Center

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.
4:25 p.m. Closing Remarks
Hortensia Amaro (she/her), Committee Chair
4:30 p.m. Adjourn Public Session

MEETING 4

NOVEMBER 30, 2023, AND DECEMBER 1, 2023
KECK 201

The National Academy of Sciences
2101 Constitution Ave NW
Washington, DC 20418

DAY 1: November 30, 2023

9:15 a.m. Welcome and Opening Remarks
Hortensia Amaro (she/her), Committee Chair
9:20 a.m. Expert Panel: Variations in Sex Traits and Implications for Disability
Moderators:

Amy Tishelman, Ph.D. (she/her), Research Associate Professor, Psychology Department, Boston College

Selma Feldman Witchel, M.D. (she/her), Professor Emerita, University of Pittsburgh School of Medicine; University of Pittsburgh Medical Center, Children’s Hospital of Pittsburgh

Panelists:

Katharine Dalke, Ph.D. (she/her, they/them), Associate Professor of Clinical Psychiatry at University of Pennsylvania Perelman School of Medicine

Veronica Gomez-Lobo, M.D. (she/her), Division Chief of Gynecology, Children’s National Medical Center; and Director, Positive Reevaluation of Urogenital Differences (PROUD) Clinic

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.

Louise Fleming, Ph.D., M.S.N.-E.D., RN (she/her), Professor and Associate Dean, Undergraduate Programs, The University of North Carolina at Chapel Hill School of Nursing; Immediate Past Chair of the CARES Foundation

Noi Liang, M.B.A., BCPA (she/her), Patient Advocate, Children’s Hospital Colorado; Member, SOAR Clinic (an interdisciplinary differences of sexual development/intersex care team)

Justin Tsang (he/him), Disability Rights Advocate; Advocate for Intersex People; Board Member, American Association for People with Disabilities

10:45 a.m. Patient Panel: Chronic Disease and Disability for Transgender and Gender Diverse People
Moderators:

Raksha Jain, M.D. (she/her/hers), Professor, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center; Medical Director, Adult Cystic Fibrosis Program

Dinushika Mohottige, M.D., M.P.H. (she/her/hers), Assistant Professor, Institute of Health Equity Research at the Icahn School of Medicine at Mount Sinai; Mount Sinai Barbara T. Murphy Division of Nephrology

Panelists:

Jess Walters (they/them): Disability Justice Advocate; Health Equity & Justice Fellow at the Center for Health Humanities and Ethics, University of Virginia

Anonymous Panelist 2
11:30 a.m. Closing Remarks
Hortensia Amaro (she/her), Committee Chair
11:35 a.m. Adjourn Public Session
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.

Day 2: December 1, 2023

9:15 a.m. Introduction to Public Meeting
Hortensia Amaro (she/her), Committee Chair
9:20 a.m. Patient and Provider Panel—Transgender and Gender Diverse People with Cancer: Cancer Treatment, Care, and Implications for Disability
Moderator:

Ash Alpert, M.D., M.F.A. (they/them/theirs), Instructor of Medicine (Hematology), Yale University School of Medicine

Panelists:

Yee Won Chong (he/they/dia), Filmmaker: Trans Dudes with Lady Cancer

Roman Ruddick (they/them), Cofounder, Transgender Cancer Patient Project

Charlie Manzano (he/him), Cofounder, Transgender Cancer Patient Project

10:20 a.m. Closing Remarks
Hortensia Amaro (she/her), Committee Chair
10:25 a.m. Adjourn Public Session
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.
Page 447
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.
Page 448
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.
Page 449
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.
Page 450
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.
Page 451
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Sex and Gender Identification and Implications for Disability Evaluation. Washington, DC: The National Academies Press. doi: 10.17226/27775.
Page 452
Next Chapter: Appendix B: Committee Member Biosketches
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.